Skip to content

Ardelyx ARDX Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's accrued manufacturing costs?
Ardelyx (ARDX) reported accrued manufacturing costs of $9.38M in Q1 2026.
How has Ardelyx's accrued manufacturing costs changed year-over-year?
Ardelyx's accrued manufacturing costs increased by 30.9% year-over-year, from $7.17M to $9.38M.
What is the long-term trend for Ardelyx's accrued manufacturing costs?
Over 5 years (2020 to 2025), Ardelyx's accrued manufacturing costs has grown at a 27.5% compound annual growth rate (CAGR), from $5.67M to $19.11M.